The epidemiology of ventilator-associated pneumonia in a network of community hospitals: A prospective multicenter study

Infection Control and Hospital Epidemiology

Volumn 34, Issue 7, 2013, Pages 657-662

  Lee, Mi Suk ^a,b   Walker, Vanessa ^a   Chen, Luke F ^a   Sexton, Daniel J ^a   Anderson, Deverick J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; COMMUNITY HOSPITAL; DISEASE SURVEILLANCE; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; KLEBSIELLA; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; PREDICTION; PROSPECTIVE STUDY; PSEUDOMONAS; SURVIVAL; VENTILATOR ASSOCIATED PNEUMONIA;

AGED; FEMALE; HEALTH FACILITY SIZE; HOSPITALS, COMMUNITY; HUMANS; INCIDENCE; KLEBSIELLA INFECTIONS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES; PSEUDOMONAS INFECTIONS; SOUTHEASTERN UNITED STATES;

EID: 84878751983     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/670991     Document Type: Article

References (26)

1. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008;300:805-813.
2. Bercault N, Boulain T. Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case control study. Crit Care Med 2001;29: 2303-2309.
3. Hortal J, Giannella M, Pérez MJ, et al. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med 2009;35:1518-1525.
4. Magret M, Amaya-Villar R, Garnacho J, et al. Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results from EU-VAP study. J Trauma 2010;69:849-854.
5. Vanhems P, Bénet T, Voirin N, et al. Early-onset ventilator-associated pneumonia incidence in intensive care units: a surveillance-based study. BMC Infect Dis 2011;6;11:236.
6. Chung DR, Song JH, Kim SH, et al. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med 2011;184:1409-1417.
7. Ibrahim EH, Tracy L, Hill C, Fraser VJ, Kollef MH. The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. Chest 2001;120:555-561.
8. Centers for Disease Control and Prevention. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-485.
9. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) report, data summary for 2009, deviceassociated module. Am J Infect Control 2011;39:349-367.
10. Anderson DJ, Miller BA, Chen LF, et al. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect Control Hosp Epidemiol 2011;32:315-322.
11. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332.
12. Sundar KM, Nielsen D, Sperry P. Comparison of ventilator-associated pneumonia (VAP) rates between different ICUs: implications of a zero VAP rate. J Crit Care 2012;27:26-32.
13. DePalo VA, McNicoll L, Cornell M, Rocha JM, Adams L, Pronovost PJ. The Rhode Island ICU collaborative: a model for reducing central line-associated bloodstream infection and ventilator-associated pneumonia statewide. Qual Saf Health Care 2010;19:555-561.
14. Bouadma L, Deslandes E, Lolom I, et al. Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 2010; 51:1115-1122.
15. Blot S, Lisboa T, Angles R, Rello J. Prevention of VAP: is zero rate possible? Clin Chest Med 2011;32:591-599.
16. Anderson DJ, Hartwig MG, Pappas T, et al. Surgical volume and the risk of surgical site infection in community hospitals: size matters. Ann Surg 2008;247:343-349.
17. Kahn JM, Goss CH, Heagerty PJ, Kramer AA, O'Brien CR, Rubenfeld GD. Hospital volume and the outcomes of mechanical ventilation. N Engl J Med 2006;355:41-50.
18. Klompas M, Kleinman KP, Karcz A. Variability in mean duration of mechanical ventilation among community hospitals. Infect Control Hosp Epidemiol 2012;33:635-637.
19. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129:433-440.
20. Ranes JL, Gordon SM, Chen P, et al. Predictors of long-term mortality in patients with ventilator-associated pneumonia. Am J Med 2006;119:e13-e19.
21. Tejerina E, Frutos-Vivar F, Restrepo MI, et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 2006;21:56-65.
22. Kollef MH, Shorr A, Tabak YP, Gupta V, Liu LZ, Johannes RS. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005;128:3854-3862.
23. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 2010;38:95-104.
24. Klompas M, Platt R. Ventilator-associated pneumonia: the wrong quality measure for benchmarking. Ann Intern Med 2007; 147:803-805.
25. Klompas M. Interobserver variability in ventilator-associated pneumonia surveillance. Am J Infect Control 2010;38:237-239.
26. Improving surveillance for ventilator-associated events in adults. Center for Disease Control and Prevention (CDC) website. http://www.cdc.gov/nhsn/PDFs/vae/CDC_VAE_CommunicationsSummary-forcompliance_20120313.pdf. Accessed July 10, 2012.